BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 22460555)

  • 1. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice.
    Gupte M; Thatcher SE; Boustany-Kari CM; Shoemaker R; Yiannikouris F; Zhang X; Karounos M; Cassis LA
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1392-9. PubMed ID: 22460555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice.
    Shoemaker R; Tannock LR; Su W; Gong M; Gurley SB; Thatcher SE; Yiannikouris F; Ensor CM; Cassis LA
    Biol Sex Differ; 2019 Sep; 10(1):45. PubMed ID: 31484552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism.
    Wang Y; Shoemaker R; Thatcher SE; Batifoulier-Yiannikouris F; English VL; Cassis LA
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1066-75. PubMed ID: 26078188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet.
    Gupte M; Boustany-Kari CM; Bharadwaj K; Police S; Thatcher S; Gong MC; English VL; Cassis LA
    Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R781-8. PubMed ID: 18650320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice.
    Wang Y; Shoemaker R; Powell D; Su W; Thatcher S; Cassis L
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H459-H468. PubMed ID: 27986659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
    Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
    Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ACE2 in cardiac myocytes and fibroblasts.
    Gallagher PE; Ferrario CM; Tallant EA
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2373-9. PubMed ID: 18849338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
    Wysocki J; Ye M; Rodriguez E; González-Pacheco FR; Barrios C; Evora K; Schuster M; Loibner H; Brosnihan KB; Ferrario CM; Penninger JM; Batlle D
    Hypertension; 2010 Jan; 55(1):90-8. PubMed ID: 19948988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.
    Ali Q; Wu Y; Hussain T
    Kidney Int; 2013 Nov; 84(5):931-9. PubMed ID: 23823602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension.
    Xue B; Zhang Z; Beltz TG; Guo F; Hay M; Johnson AK
    Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H191-8. PubMed ID: 24858844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
    Feng Y; Xia H; Cai Y; Halabi CM; Becker LK; Santos RA; Speth RC; Sigmund CD; Lazartigues E
    Circ Res; 2010 Feb; 106(2):373-82. PubMed ID: 19926873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats.
    Lee SH; Lee YH; Jung SW; Kim DJ; Park SH; Song SJ; Jeong KH; Moon JY; Ihm CG; Lee TW; Kim JS; Sohn IS; Lee SY; Kim DO; Kim YG
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F670-F682. PubMed ID: 31339773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.
    Muñoz MC; Burghi V; Miquet JG; Giani JF; Banegas RD; Toblli JE; Fang Y; Wang F; Bartke A; Dominici FP
    J Endocrinol; 2014 May; 221(2):215-27. PubMed ID: 24756097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
    Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
    Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.
    Gallagher PE; Ferrario CM; Tallant EA
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1169-74. PubMed ID: 18768926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.